Accessibility navigation

Cardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patients

Ng, K. W., Allen, M. L., Desai, A., Macrae, D. and Pathan, N. (2012) Cardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patients. Circulation, 125. pp. 721-728. ISSN 1524-4539

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1161/CIRCULATIONAHA.111.063784


Interest in the effects of insulin on the heart came with the recognition that hyperglycemia in the context of myocardial infarction is associated with increased risks of mortality, congestive heart failure, or cardiogenic shock. More recently, instigated by research findings on stress hyperglycemia in critical illness, this interest has been extended to the influence of insulin on clinical outcome after cardiac surgery. Even in nondiabetic individuals, stress hyperglycemia commonly occurs as a key metabolic response to critical illness, eg, after surgical trauma. It is recognized as a major pathophysiological feature of organ dysfunction in the critically ill. The condition stems from insulin resistance brought about by dysregulation of key homeostatic processes, which implicates immune/inflammatory, endocrine, and metabolic pathways. It has been associated with adverse clinical outcomes, including increased mortality, increased duration of mechanical ventilation, increased intensive care unit (ICU) and hospital stay, and increased risk of infection. Hyperglycemia in critical illness is managed with exogenous insulin as standard treatment; however, there is considerable disagreement among experts in the field as to what target blood glucose level is optimal for the critically ill patient. Conventionally, the aim of insulin therapy has been to maintain blood glucose levels below the renal threshold, typically 220 mg/dL (12.2 mmol/L). In recent years, some have advocated tight glycemic control (TGC) with intensive insulin therapy (IIT) to normalize blood glucose levels to within the euglycemic range, typically 80 to 110 mg/dL (4.4–6.1 mmol/L).

Item Type:Article
Divisions:No Reading authors. Back catalogue items
ID Code:28104
Uncontrolled Keywords:Insulin Glucose Inflammation Stress Surgery
Publisher:American Heart Association

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation